What Perioperative Nurses and Infection Preventionists Need to Know About the Joint Commission’s 2026 “Accreditation 360” Infection Control Standards | Aerobiotix

What Perioperative Nurses and Infection Preventionists Need to Know About the Joint Commission’s 2026 “Accreditation 360” Infection Control Standards

J. Hudson Garrett Jr., Ph.D., MSN, MPH, MBA, IP-BC, PLNC, CFER, AS-BC, VA-BC, CMRP, HACP, HACP-IC, HACP-PE, LTC-CIP, CIC, AL-CIP, CAIP, DICO-C, CPPS, CCHR-S, CPHQ, CVAHP, CPXP, CDIPC, CPHRM, CHIPP-B, FACDONA, FAAPM, eFACHDM, FAPIC, FAOM, FRSPH, FNAP, FAHVAP, FACHE, FSHEA, FIDSA

The Joint Commission’s new Accreditation 360 infection prevention and control (IPC) standards, effective January 1, 2026, represent a clear shift: infection control is now explicitly a system-level, auditable, and operational expectation across ambulatory and hospital settings. For perioperative nurses and infection preventionists, the changes are practical and immediate — they require clearer governance, tighter surveillance and documentation, stronger cross-functional collaboration, and demonstrable readiness for infectious threats and construction-related air quality risks.

At the core of the new framework is formalized accountability. The governing body must be clearly responsible for implementation, performance, and sustainability of the IPC program (IC.05.01.01). Infection preventionists are now called out for a defined set of responsibilities: program development and documentation, competency-based staff education, auditing adherence to IPC policies, and close collaboration with quality improvement, sterile processing, antibiotic stewardship, and facilities/water-management programs (IC.04.01.01). Practically, this means perioperative leaders should expect to be asked for evidence — charters, committee minutes, audit logs, training rosters, and policy crosswalks — during routine reviews and surveys.

Surveillance and risk-based prioritization are emphasized. Hospitals must identify risks for infection and prioritize IPC activities using local epidemiology, service lines, and public-health alerts (IC.06.01.01). For OR teams, that requires translating surveillance data into targeted perioperative workplans: which procedures, patient populations, or rooms are higher-risk this season (e.g., RSV, influenza, CRE or Candida auris clusters), and which mitigation steps are needed immediately. Expect surveyors to probe how your OR surveillance (SSI tracking, environmental monitoring, and turnover audits) influences daily practice and resource allocation.

Environmental controls and construction preparedness are elevated. The standards restate well-accepted design criteria (NFPA/ASHRAE references) for critical care ventilation and require preconstruction infection control risk assessments (ICRA) whenever demolition, renovation, or maintenance could affect air quality. For perioperative teams, this translates into formalized plans whenever ORs or adjacent spaces are modified — placement of temporary HEPA/air-disinfection units, turnover scheduling changes, and additional surveillance during construction must be documented and tied to the ICRA. Certain portable, validated air disinfection devices are also clinically proven to reduce Surgical Site Infections when used according to the manufacturer’s instructions for use. Likewise, the guidance for bedside aerosol-generating procedures (e.g., bronchoscopy) explicitly calls for mitigation strategies such as clinically-validated air disinfection units, scheduling at the end of day, or other controls when procedures occur in non-controlled environments. These are no longer optional “best practices” — they must be present in policy and implemented as needed. One of the most significant changes in the new standards is the comprehensive focus on the multilayered approach to Infection Prevention and Control that includes Surveillance, Prevention, and Control. Healthcare facilities should seek medical devices and technologies that address all three aspects of this approach.

Preparedness for high-consequence pathogens and workforce safety are explicit expectations. Hospitals must have protocols for identifying, isolating, informing public health and internal stakeholders, and protecting staff with appropriate PPE and donning/doffing procedures (IC.07.01.01). The standards also mandate policies for staff screening, immunization, and management of exposures. Perioperative leaders should ensure staff competency records, fit-testing, and exposure management processes are current and easily retrievable for survey review or an outbreak response.

  • What this means operationally: concrete actions for perioperative and IP teams:
    Strengthen governance artifacts: update your perioperative section of the IPC program, add OR-specific charters, define decision rights, and ensure committee minutes reflect actions and follow-up. (See the responsibilities outlined under IC.04.01.01.)
  • Make surveillance actionable: link SSI and perioperative process audits (turnover practices, IFU adherence, environmental sampling where used) to risk registers and prioritized mitigation plans. Document how surveillance drives interventions and resource requests.
  • Document environmental controls: maintain placement photos, device runtime logs, HVAC certification, and any temporary mitigation measures (HEPA/portable air disinfection units) used during construction or bedside aerosol procedures. Ensure sampling SOPs and chain-of-custody are available if you perform particle/CFU testing. Utilize devices with appropriate FDA clearance and/or FDA 510K exemption that are manufactured in FDA-registered manufacturing facilities to ensure the highest levels of quality.
  • Human factors and competency: Tie training rosters and competency checklists to frontline staff. Keep proctoring evidence for new devices and document any changes to workflow that result from device deployment.
  • Plan for outbreaks and special pathogens: keep isolation and notification protocols up to date and rehearse them with simulation or tabletop exercises so teams can demonstrate readiness.

Survey readiness now favors transparency and auditable artifacts. Surveyors will expect to see not only policies but evidence of implementation: training logs, surveillance outputs, sampling results (if used), environmental assessments for construction and bedside procedures, and documented governance decisions. Prepare “evidence pages” that combine concise narrative, the relevant policy/IFU excerpt, and exportable data (logs, sampling results, photos) for each high-risk OR area.

Finally, operational alignment matters: collaborate with facilities/engineering to ensure HVAC records and ICRA documents are current; work with procurement/value analysis to ensure device IFUs are integrated into local SOPs; partner with quality and finance to quantify pilot results and scale successful interventions. The new standards create both an obligation and an opportunity: programs that can turn IPC activities into documented, measurable, and governed processes will not only meet accreditation requirements but will also reduce harm and strengthen clinician confidence.

For perioperative nurses and infection preventionists, the takeaway is straightforward — convert local expertise into auditable systems. Start by inventorying your OR evidence (training, governance, surveillance, environmental controls) and closing the most visible gaps: governance charters, surveillance-to-action links, construction ICRAs, documented mitigation for aerosol procedures, and clear staffing/competency records. By doing so, you’ll meet the new Accreditation 360 expectations and, more importantly, protect patients and staff where it matters most.

 

Aerobiotix’s Illuvia Sense is uniquely positioned to help healthcare facilities exceed guidelines and reduce risk. This FDA-registered Class II medical device delivers continuous air decontamination and real-time monitoring, ensuring optimal air quality.

About the Author

J. Hudson Garrett Jr., Ph.D., MSN, MPH, MBA, IP-BC, PLNC, CFER, AS-BC, VA-BC, CMRP, HACP, HACP-IC, HACP-PE, LTC-CIP, CIC, AL-CIP, CAIP, DICO-C, CPPS, CCHR-S, CPHQ, CVAHP, CPXP, CDIPC, CPHRM, CHIPP-B, FACDONA, FAAPM, eFACHDM, FAPIC, FAOM, FRSPH, FNAP, FAHVAP, FACHE, FSHEA, FIDSA

Dr. Garrett is an Adjunct Assistant Professor of Medicine in the Division of Infectious Diseases at the University of Louisville School of Medicine. He is Board Certified in Infection Prevention and Control, Advanced Leadership in Infection Control, Patient Safety, Healthcare Risk Management, and Healthcare Management and Leadership. Dr. Garrett is a Liaison to the AORN Guidelines Advisory Board.

 

Dr. Garrett